The 'Secondary' Specialist is Now Your Primary Driver: Why Cardiologists Are Outperforming Diabetologists in PSP Engagement

The 'Secondary' Specialist is Now Your Primary Driver: Why Cardiologists Are Outperforming Diabetologists in PSP Engagement
New data shows that "non-primary" specialists aren't just participating, they are engaging with higher velocity than the core therapeutic owners.

In metabolic health, the Diabetologist is the assumed "captain" of the ship. They own the largest patient volume and are the primary target for Patient Support Programs (PSPs). 

But as our program matures, a startling trend has emerged in the data. 

While Diabetologists still represent the largest total number of active doctors, they are no longer the most active on a per-capita basis in our programs. 

The Velocity Flip Our latest analysis shows that Cardiologists are now enrolling patients at a higher velocity than Diabetologists. 

  • Diabetologists: High volume, steady engagement. 

  • Cardiologists: Lower total volume, but 3.7% higher enrollment per doctor. 

This shatters the assumption that "secondary" specialists (Endocrinologists, Cardiologists, and now Internal Medicine) are passive observers. Collectively, these cross-therapeutic specialists now account for 42.5% of the entire active HCP base in our Patient Support Programs. 

Why the Shift? This "Cardio-Metabolic" surge suggests a change in clinical reality. Cardiologists are no longer just managing complications; they are actively initiating metabolic therapies to protect the heart. They need a PSP not just for "support," but as a risk management tool. 

For them, the platform isn't an "add-on"; it's a safety net for patients they see less frequently than a Diabetologist might. 

The Strategic Takeaway If your PSP strategy treats Cardiologists and Endocrinologists as "Tier 2" targets with "Tier 2" budgets, you are missing your most engaged audience. Reconsider. 

The data proves the patient journey is now truly cross-therapeutic. Your platform must be equally robust for the Cardiologist managing risk as it is for the Diabetologist managing sugar. The "secondary" user has become a primary driver of success.